Diabetic Kidney Disease: Much Progress, But Still More to Do

por Molitch, Mark E.
Publicado 2015

Management of diabetes mellitus in patients with chronic kidney disease

por Hahr, Allison J., Molitch, Mark E.
Publicado 2015

Improvement in Insulin Sensitivity During Mifepristone Treatment of Cushing Syndrome:Early and Late Effects

por Wallia, Amisha, Colleran, Kathleen, Purnell, Jonathan Q., Gross, Coleman, Molitch, Mark E.
Publicado 2013

Hyperglycemia in the Posttransplant Period: NODAT vs Posttransplant Diabetes Mellitus

por Gupta, Suruchi, Pollack, Teresa, Fulkerson, Candice, Schmidt, Kathleen, Oakes, Diana Johnson, Molitch, Mark E, Wallia, Amisha
Publicado 2018

Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly

por Salvatori, Roberto, Nachtigall, Lisa B., Cook, David M., Bonert, Vivien, Molitch, Mark E., Blethen, Sandra, Chang, Stephen
Publicado 2009

Development and Progression of Renal Insufficiency With and Without Albuminuria in Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial and the Epidemiology...

por Molitch, Mark E., Steffes, Michael, Sun, Wanjie, Rutledge, Brandy, Cleary, Patricia, de Boer, Ian H., Zinman, Bernard, Lachin, John
Publicado 2010

Development of a Predictive Model for Hyperglycemia in Nondiabetic Recipients After Liver Transplantation

por Zelada, Henry, VanWagner, Lisa B., Pollack, Teresa, Higginbotham, Devan, Zhao, Lihui, Yang, Amy, Molitch, Mark E., Wallia, Amisha
Publicado 2018

Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline

por Freda, Pamela U., Beckers, Albert M., Katznelson, Laurence, Molitch, Mark E., Montori, Victor M., Post, Kalmon D., Vance, Mary Lee
Publicado 2011

Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis

por Woodmansee, Whitney W., Gordon, Murray B., Molitch, Mark E., Ioachimescu, Adriana G., Carver, Don W., Mirakhur, Beloo, Cox, David, Salvatori, Roberto
Publicado 2018

Urinary Angiotensinogen in Patients With Type 1 Diabetes With Microalbuminuria: Gender Differences and Effect of Intensive Insulin Therapy

por Navarro, Jessica, Sanchez, Alejandro, Ba Aqeel, Sheeba H., Ye, Minghao, Rehman, Mohammed Z., Wysocki, Jan, Rademaker, Alfred, Molitch, Mark E., Batlle, Daniel
Publicado 2022

The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome

por Klibanski, Anne, Melmed, Shlomo, Clemmons, David R., Colao, Annamaria, Cunningham, Regina S., Molitch, Mark E., Vinik, Aaron I., Adelman, Daphne T., Liebert, Karen J. P.
Publicado 2009

Contextualized analysis of a needs assessment using the Theoretical Domains Framework: a case example in endocrinology

por Lazure, Patrice, Bartel, Robert C, Biller, Beverly MK, Molitch, Mark E, Rosenthal, Stephen M, Ross, Judith L, Bernsten, Brock D, Hayes, Sean M
Publicado 2014

Circulating Vitamin D Metabolites and Subclinical Atherosclerosis in Type 1 Diabetes

por Sachs, Michael C., Brunzell, John D., Cleary, Patricia A., Hoofnagle, Andrew N., Lachin, John M., Molitch, Mark E., Steffes, Michael W., Zinman, Bernard, de Boer, Ian H.
Publicado 2013

Diabetic Kidney Disease– A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

por Molitch, Mark E., Adler, Amanda I., Flyvbjerg, Allan, Nelson, Robert G., So, Wing-Yee, Wanner, Christoph, Kasiske, Bertram L., Wheeler, David C., de Zeeuw, Dick, Mogensen, Carl E.
Publicado 2014

PMON166 Safety Comparison of 40- vs 60-mg/day Doses of Oral Octreotide Capsules for Treatment of Acromegaly in the CHIASMA OPTIMAL Trial

por Elenkova, Atanaska, Jensterle, Mojca, Kennedy, Laurence, Manning, Patrick, Melmed, Shlomo, Strasburger, Christian J, Samson, Susan, Nachtigall, Lisa, Fleseriu, Maria, Molitch, Mark E, Giustina, Andrea, Haviv, Asi, Biermasz, Nienke
Publicado 2022

LBMON178 2nd Year Outcomes Of The Open-label Extension Of Chiasma Optimal, A Phase 3 Study Of Oral Octreotide Capsules In Acromegaly

por Samson, Susan, Nachtigall, Lisa, Fleseriu, Maria, Molitch, Mark E, Giustina, Andrea, Haviv, Asi, Biermasz, Nienke, Kennedy, Laurence, Jensterle, Mojca, Manning, Patrick, Elenkova, Atanaska, Melmed, Shlomo, Strasburger, Christian J
Publicado 2022

THU057 Predictors Of Response To Oral Octreotide Capsules In Patients With Acromegaly In A Large Prospective International Trial

por Fleseriu, Maria, Dreval, Alexander, Pokramovich, Yulia, Bondar, Irina, Isaeva, Elena, Macut, Djuro P, Molitch, Mark E, Leonova, Nina Vasiljevna, Raverot, Gerald, Haviv, Asi, Biermasz, Nienke, Strasburger, Christian Joseph, Melmed, Shlomo
Publicado 2023

Biomarkers of tubulointerstitial damage and function in type 1 diabetes

por de Boer, Ian H, Gao, Xiaoyu, Bebu, Ionut, Hoofnagle, Andrew N, Lachin, John M, Paterson, Andrew, Perkins, Bruce A, Saenger, Amy K, Steffes, Michael W, Zinman, Bernard, Molitch, Mark E
Publicado 2017

Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease

por Fleseriu, Maria, Pivonello, Rosario, Young, Jacques, Hamrahian, Amir H., Molitch, Mark E., Shimizu, Chikara, Tanaka, Tomoaki, Shimatsu, Akira, White, Tracy, Hilliard, Annie, Tian, Chuan, Sauter, Nicholas, Biller, Beverly MK, Bertagna, Xavier
Publicado 2015

A Pituitary Society update to acromegaly management guidelines

por Fleseriu, Maria, Biller, Beverly M. K., Freda, Pamela U., Gadelha, Monica R., Giustina, Andrea, Katznelson, Laurence, Molitch, Mark E., Samson, Susan L., Strasburger, Christian J., van der Lely, A. J., Melmed, Shlomo
Publicado 2020